Enza Maria Valente: Pursuing Parkinson Disease

Credit: JASON VARNEY/http://www.varneyphoto.comVARNEYPHOTO.COM" /> Credit: JASON VARNEY/http://www.varneyphoto.comVARNEYPHOTO.COM As a medical student at Catholic University in Rome, Enza Maria Valente remembers helping her genetics professor, a priest in his sixties, as he struggled to calculate probabilities for passing on a genetic disorder. "I would just pick up the answer even before he finished the calculations," she says.Despite her pedigree predilection, Va

Written byEugene Russo
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

As a medical student at Catholic University in Rome, Enza Maria Valente remembers helping her genetics professor, a priest in his sixties, as he struggled to calculate probabilities for passing on a genetic disorder. "I would just pick up the answer even before he finished the calculations," she says.

Despite her pedigree predilection, Valente didn't enter the field - not yet anyway. Hailing from a family of physicians, her mother, a pediatrician, strongly encouraged Valente to take over the family practice. She resisted, pursuing neurophysiology instead. But, she says she got bored just seeing patients, save the occasional unusual phenotype.

She started working on movement disorders with a group at her university. When they needed someone to go to University College London (UCL) to study a collection of Italian families that carried genes for dystonia, Valente jumped at the chance. With encouragement from her London colleagues, Valente decided to work ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies